Cambridge biogerontologist Aubrey de Grey: "Why the prospect of dramatic life extension matters now"

"Many people say curing aging might be a bad idea, but deep down we all know that's nonsense. We cling to silly doubts about it only because we don't want to get our hopes up too soon. Eventually, though, this will stop being appropriate: we'll know enough to wage a 'war on aging' with a fair chance of winning it in a few decades. At that time, ambivalence will cost lives - 100,000 lives each day - by slowing down the research and development to turn our knowledge into working rejuvenation therapies. I will explain that we have recently reached that point: the time for the war on aging has arrived." - Aubrey de Grey

With the Baby Boomer generation aging and the current rapid advances in biotechnology and medicine, aging will soon come to the forefront of the public consciousness. Do not miss this rare opportunity to hear from a leading biogerontologist of worldwide repute.

As of 2005, de Grey's current work at Cambridge centered around a detailed plan called Strategies for Engineered Negligible Senescence (SENS) which is aimed at preventing age-related physical and cognitive decline. He is also the co-founder and chief scientist of the Methuselah Mouse Prize, a prize designed to accelerate research into effective life extension interventions by awarding monetary prizes to researchers who extend the lifespan of mice to unprecedented lengths. He has been interviewed in recent years in many news sources, including the BBC, the New York Times, Fortune Magazine, and Popular Science.